September 15-16, 2022
La Jolla, CA, USA
September 15-16, 2022
La Jolla, CA, USA
In recent years, sample management teams have continued to evolve to meet stakeholder needs including management of non-small molecule modalities and an increased emphasis on sample quality control measures. In this session we will explore how teams across the industry are tackling some of these challenges.
Chair: Kristen Nailor (Genentech)
Speakers
Wilfredo Pinto (Merck)
Characterization of the Merck Sample Collection by UPLC-MS and Evaluation of the Data Using Virscidian
Bhagyashree Khunte (Pfizer)
Towards Ultra-High-Throughput Sample QC and Beyond
Lisa Nixon (GlaxoSmithKline)
Transforming Sample Management for a High-Throughput Modality Agnostic Future